4//SEC Filing
Broadfin Capital, LLC 4
Accession 0000899243-18-022576
CIK 0001103021other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 5:01 PM ET
Size
12.6 KB
Accession
0000899243-18-022576
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common Stock
2018-08-14+3,124→ 3,124 total - Exercise/Conversion
Restricted Stock Units
2018-08-14+3,124→ 93,123 totalExercise: $0.00Exp: 2022-08-01→ Common Stock (3,124 underlying)
Holdings
- 4,278,819(indirect: See Footnote)
Common Stock
Broadfin Capital, LLC
Director
Transactions
- Exercise/Conversion
Common Stock
2018-08-14+3,124→ 3,124 total - Exercise/Conversion
Restricted Stock Units
2018-08-14+3,124→ 93,123 totalExercise: $0.00Exp: 2022-08-01→ Common Stock (3,124 underlying)
Holdings
- 4,278,819(indirect: See Footnote)
Common Stock
KOTLER KEVIN
Director
Transactions
- Exercise/Conversion
Common Stock
2018-08-14+3,124→ 3,124 total - Exercise/Conversion
Restricted Stock Units
2018-08-14+3,124→ 93,123 totalExercise: $0.00Exp: 2022-08-01→ Common Stock (3,124 underlying)
Holdings
- 4,278,819(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units ("RSUs") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs vest as follows: (i) 18,123 RSUs vest in the first open window following the Company's 2019 Annual Meeting of Stockholders, (ii) 30,000 RSUs vest in the first open window following the Company's 2020 Annual Meeting of Stockholders, (iii) 30,000 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (iv) 15,000 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders.
- [F2]There are 4,278,819 shares of Common Stock held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC, and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Kevin Kotler affirmatively (i) disclaims beneficial ownership of the reportable securities, (ii) states that this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 ("Section 16") of the Securities Exchange Act of 1934, as amended (the "Act") or any other purpose, except to the extent of his pecuniary interest therein, and (iii) disclaims being a "group" for purposes of Section 16.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001511901
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 5:01 PM ET
- Size
- 12.6 KB